Skip to main content
. 2011 May;55(5):2084–2091. doi: 10.1128/AAC.01808-10

Table 1.

Activities of antimicrobial agents against 151 Nocardia isolates

Bacterium (no of isolates tested) and antimicrobial agent MIC (μg/ml)
Susceptibility (%)a
Range 50% 90% S I R
N. brasiliensis (60)
    Amoxicillin-clavulanic acid 0.5–32 1 2 59 (98) 1 (2)
    Cefoxitin 1–>128 2 8
    Ceftriaxone 0.5–32 2 4 57 (95) 3 (5) 0 (0)
    Meropenem 0.5–8 2 4
    Ertapenem 0.25–8 4 8
    Imipenem 0.5–>32 2 >32 28 (47) 3 (5) 29 (48)
    Doripenem 0.5–8 2 4
    Azithromycin 16–>128 32 >128
    Ciprofloxacin 0.5–8 8 8 1 (2) 0 (0) 59 (98)
    Nemonoxacin 0.12–1 0.25 0.5
    Gemifloxacin 0.06–2 0.25 0.5
    Levofloxacin 1–>16 4 8
    Moxifloxacin 0.12–2 1 1
    Linezolid 1–16 4 8 59 (98) 1 (2)
    Vancomycin 0.5–>128 128 >128
    Daptomycin 64–>128 128 >128
    Sulfamethoxazole 0.5–64 4 8 59 (98) 1 (2)
    Amikacin 0.25–4 1 2 60 (100) 0 (0)
    Tigecycline 0.25–1 0.25 1
N. cyriacigeorgica (24)
    Amoxicillin-clavulanic acid 4–16 16 16 9 (38) 14 (58) 1 (4)
    Cefoxitin 0.12–>16 4 16
    Ceftriaxone 0.25–16 2 8 23 (96) 1 (4) 0 (0)
    Meropenem 1–4 4 4
    Ertapenem 2–8 4 8
    Imipenem 0.5–>4 1 2 24 (100) 0 (0) 0 (0)
    Doripenem 1–8 4 4
    Azithromycin 128–>128 >128 >128
    Ciprofloxacin 0.12–128 16 64 0 (0) 0 (0) 24 (100)
    Nemonoxacin 0.25–2 1 2
    Gemifloxacin 2–8 2 4
    Levofloxacin 8–>32 16 32
    Moxifloxacin 2–4 4 4
    Linezolid 2–16 4 4 23 (96) 1 (4)
    Vancomycin 16–>128 128 >128
    Daptomycin 128–>128 128 >128
    Sulfamethoxazole 2–16 4 4 24 (100) 0 (0)
    Amikacin 0.5–2 1 2 24 (100) 0 (0)
    Tigecycline 0.5–4 2 4
N. farcinica (12)
    Amoxicillin-clavulanic acid 0.5–8 1 4 12 (100) 0 (0) 0 (0)
    Cefoxitin 0.5–>128 32 >128
    Ceftriaxone 1–>64 32 64 3 (25) 5 (42) 4 (33)
    Meropenem 0.5–>8 4 4
    Ertapenem 0.5–>8 8 8
    Imipenem 0.25–>4 1 2 12 (100) 0 (0) 0 (0)
    Doripenem 0.25–>4 4 4
    Azithromycin 128–>128 >128 >128
    Ciprofloxacin 0.5–128 8 16 6 (50) 1 (8) 5 (42)
    Nemonoxacin 0.03–1 0.25 1
    Gemifloxacin 0.03–2 0.12 0.5
    Levofloxacin 0.12–16 4 8
    Moxifloxacin 0.06–8 1 2
    Linezolid 1–4 4 4 12 (100)
    Vancomycin 2–>128 128 >128
    Daptomycin 64–>128 128 >128
    Sulfamethoxazole 2–64 8 32 11 (92) 1 (8)
    Amikacin 1–4 1 4 12 (100) 0 (0)
    Tigecycline 0.25–8 1 8
N. beijingensis (9)
    Amoxicillin-clavulanic acid 1–32 4 (44) 4 (44) 1 (11)
    Cefoxitin 1–>4
    Ceftriaxone 0.25–16 7 (78) 2 (22) 0 (0)
    Meropenem 0.25–2
    Ertapenem 2–4
    Imipenem 0.5–>8 5 (56) 4 (44)
    Doripenem 1–2
    Azithromycin 64–>128
    Ciprofloxacin 2–128 0 (0) 4 (44) 5 (56)
    Nemonoxacin 0.5–8
    Gemifloxacin 0.25–16
    Levofloxacin 4–16
    Moxifloxacin 1–32
    Linezolid 2–4 9 (100)
    Vancomycin 128–>128
    Daptomycin 64–>>128
    Sulfamethoxazole 1–4 9 (100) 0 (0)
    Amikacin 0.12–0.5 8 (89) 1 (11)
    Tigecycline 0.12–8
N. otitidiscaviarum (8)
    Amoxicillin-clavulanic acid 32–128 0 (0) 0 (0) 8 (100)
    Cefoxitin 64–>128
    Ceftriaxone 16–>128 0 (0) 1 (13) 7 (87)
    Meropenem 4–>32
    Ertapenem 16–>32
    Imipenem 16–>32 0 (0) 0 (0) 8 (100)
    Doripenem 4–>32
    Azithromycin 0.5–>128
    Ciprofloxacin 2–16 0 (0) 3 (37) 5 (63)
    Nemonoxacin 0.5–2
    Gemifloxacin 0.5–4
    Levofloxacin 1–8
    Moxifloxacin 0.25–4
    Linezolid 2–4 8 (100)
    Vancomycin 128–>128
    Daptomycin 64–128
    Sulfamethoxazole 4–32 8 (100) 0 (0)
    Amikacin 0.5–4 8 (100) 0 (0)
    Tigecycline 0.5–2
N. nova (8)
    Amoxicillin-clavulanic acid 8–64 1 (13) 3 (38) 4 (50)
    Cefoxitin 2–16
    Ceftriaxone 2–16 7 (87) 1 (13) 0 (0)
    Meropenem 0.12–2
    Ertapenem 0.5–4
    Imipenem 0.03–1 8 (100) 0 (0) 0 (0)
    Doripenem 0.25–2
    Azithromycin 0.25–>128
    Ciprofloxacin 4–16 0 (0) 0 (0) 8 (100)
    Nemonoxacin 0.25–1
    Gemifloxacin 0.5–2
    Levofloxacin 2–>32
    Moxifloxacin 0.5–4
    Linezolid 12 8 (100)
    Vancomycin 32–>128
    Daptomycin 64–>128
    Sulfamethoxazole 4–32 8 (100) 0 (0)
    Amikacin 0.12–32 7 (87) 1 (13)
    Tigecycline 0.25–8
N. asiatica (7)
    Amoxicillin-clavulanic acid 16–64 0 (0) 1 (14) 6 (86)
    Cefoxitin 0.5–2
    Ceftriaxone 0.5–1 7 (100) 0 (0) 0 (0)
    Meropenem 0.5–2
    Ertapenem 1–4
    Imipenem 0.5–1 7 (100) 0 (0) 0 (0)
    Doripenem 1–2
    Azithromycin >128
    Ciprofloxacin 64–128 0 (0) 0 (0) 7 (100)
    Nemonoxacin 16
    Gemifloxacin 16–32
    Levofloxacin >32
    Moxifloxacin 1–32
    Linezolid 1–4 7 (100)
    Vancomycin 128–>128
    Daptomycin 128–>128
    Sulfamethoxazole 2–8 7 (100) 0 (0)
    Amikacin 0.12–0.25 7 (100) 0 (0)
    Tigecycline 0.25–1
N. puris (6)
    Amoxicillin-clavulanic acid 16 0 (0) 6 (100) 0 (0)
    Cefoxitin 128–>128
    Ceftriaxone 4–>128 1 (17) 0 (0) 5 (83)
    Meropenem 2–4
    Ertapenem 4–8
    Imipenem 1–2 6 (100) 0 (0) 0 (0)
    Doripenem 2–4
    Azithromycin 4–>128
    Ciprofloxacin 8 0 (0) 0 (0) 6 (100)
    Nemonoxacin 0.5
    Gemifloxacin 1
    Levofloxacin 4–8
    Moxifloxacin 2
    Linezolid 2–4 6 (100)
    Vancomycin 0.5–>128
    Daptomycin 128–>128
    Sulfamethoxazole 0.5–16 6 (100) 0 (0)
    Amikacin 0.12–1 6 (100) 0 (0)
    Tigecycline 0.25–2
Other Nocardia spp. (17)
    Amoxicillin-clavulanic acid 1–64 8 32 10 (59) 3 (18) 4 (24)
    Cefoxitin 0.12–32 4 16
    Ceftriaxone 0.25–8 1 4 17 (100) 0 (0) 0 (0)
    Meropenem 0.12–4 1 4
    Ertapenem 0.25–16 2 8
    Imipenem 0.12–32 0.5 2 16 (94) 0 (0) 1 (6)
    Doripenem 0.12–4 2 4
    Azithromycin 1–>128 >128 >128
    Ciprofloxacin 0.25–128 8 16 4 (24) 1 (6) 12 (71)
    Nemonoxacin 0.12–16 1 16
    Gemifloxacin 0.06–32 2 32
    Levofloxacin 0.25–>32 8 16
    Moxifloxacin 0.25–32 4 32
    Linezolid 0.5–4 2 4 17 (100)
    Vancomycin 0.25–>128 128 >128
    Daptomycin 0.5–>128 128 >128
    Sulfamethoxazole 4–32 4 8 17 (100) 0 (0)
    Amikacin 0.12–32 0.5 2 16 (94) 1 (6)
    Tigecycline 0.06–4 0.5 2
a

S, susceptible; I, intermediate; R, resistant.